PEGARK SUS — Polyethylene Glycol + Electrolyte Oral Solution
💧 A Smarter Liquid Formulation for Gastrointestinal Care
Constipation can interfere with daily comfort when bowel movements become difficult or stools become hard and dry. PEGARK SUS is a Polyethylene Glycol-based oral solution formulated with Sodium Chloride, Sodium Hydrogen Carbonate, and Potassium Chloride.
With Polyethylene Glycol 13.125 gm as its key component, PEGARK SUS offers a convenient PEG + electrolyte oral solution in a 200 mL PET bottle, designed for use according to professional medical guidance.
💡 DID YOU KNOW?
Polyethylene Glycol is an osmotic agent. It works by helping retain water in the intestinal tract, increasing stool water content and supporting bowel evacuation.
FORMULATION
|
Parameter |
Product Details |
|---|---|
|
Brand |
PEGARK SUS |
|
Dosage Form |
Oral Solution |
|
Polyethylene Glycol |
13.125 gm |
|
Sodium Chloride |
0.3507 gm |
|
Sodium Hydrogen Carbonate |
0.1785 gm |
|
Potassium Chloride |
0.0466 gm |
|
Pack |
200 ml PET Bottle |
|
MRP |
₹300.94 |
WHY PEGARK SUS? KEY THERAPEUTIC ROLES
PEGARK SUS combines Polyethylene Glycol and electrolytes in a liquid formulation for its intended gastrointestinal use.
● Supports Constipation Management
Polyethylene Glycol helps increase water within the stool, which may support softer and easier-to-pass stools.
● Promotes Stool Hydration
The osmotic action of PEG helps retain water in the intestinal contents.
● Provides Osmotic Laxative Action
PEG works through a water-retaining mechanism rather than directly stimulating intestinal contractions.
● Combines PEG With Electrolytes
The formulation includes Sodium Chloride, Sodium Hydrogen Carbonate, and Potassium Chloride alongside Polyethylene Glycol.
● Available as a Convenient Liquid
The 200 ml oral solution provides a ready-to-administer liquid dosage form.
The key takeaway: PEGARK SUS brings PEG-based osmotic action and an electrolyte-containing formulation together in one oral solution.
FROM INGESTION TO ACTION — HOW PEGARK SUS WORKS
The principal ingredient, Polyethylene Glycol, remains in the gastrointestinal tract and exerts an osmotic effect. By retaining water in the intestinal lumen, PEG increases the water content of bowel contents.
This increased hydration can help improve stool consistency and support bowel evacuation.
THE ACTION IN 5 STEPS
01 — PEG Enters the GI Tract
Polyethylene Glycol passes through the digestive system.
02 — Water Is Retained
PEG helps hold water within the intestinal contents.
03 — Stool Hydration Increases
Additional water can make stool softer and more hydrated.
04 — Bowel Passage Is Supported
Hydrated stool may be easier to pass.
05 — Electrolytes Complete the Formulation
Sodium and potassium salts are incorporated alongside PEG.
In one sentence: PEGARK SUS works primarily by using the osmotic water-retaining action of Polyethylene Glycol to support bowel movement.
DOSING MADE SIMPLE — USING PEGARK SUS CORRECTLY
The appropriate PEGARK SUS dosage is individualized according to the patient's age, condition, intended use, and healthcare professional's recommendation.
The dosage regimen for constipation may differ from the regimen used when a PEG-electrolyte preparation is specifically prescribed for bowel preparation. Therefore, patients should follow the exact instructions provided for their particular use.
5 DOSING PRINCIPLES
|
Do This |
Why It Matters |
|---|---|
|
Follow the Prescribed Dose |
Helps ensure appropriate use |
|
Measure Accurately |
Avoids accidental under- or over-dosing |
|
Follow Administration Directions |
Supports correct product use |
|
Maintain Recommended Fluids |
Helps support appropriate hydration |
|
Don't Self-Increase the Dose |
Higher doses should only be used when professionally advised |
⚠️ DOSAGE ALERT: Never increase the quantity, frequency, or duration of PEGARK SUS without consulting a qualified healthcare professional.
Good gastrointestinal care starts with correct administration — follow the recommended regimen rather than adjusting the dose independently.
WHAT TO EXPECT — POSSIBLE SIDE EFFECTS
Some individuals may experience gastrointestinal reactions while using PEGARK SUS. Most are generally associated with bowel activity, while serious or unusual reactions require medical evaluation.
🟢 COMMON EFFECTS
|
Common Reaction |
Quick Insight |
|---|---|
|
Bloating |
Temporary abdominal fullness |
|
Gas |
Increased intestinal gas |
|
Abdominal Discomfort |
Mild stomach or abdominal discomfort |
|
Nausea |
Feeling sick or uneasy |
|
Loose Stools / Diarrhoea |
Increased bowel activity may cause loose stools |
🔴 SERIOUS & RARE EFFECTS
|
Serious / Rare Reaction |
What to Know |
|---|---|
|
Severe Diarrhoea |
Can lead to significant fluid loss |
|
Dehydration |
May occur with excessive fluid loss |
|
Electrolyte Disturbance |
Requires attention, particularly in susceptible individuals |
|
Severe Abdominal Symptoms |
Persistent or significant symptoms need medical assessment |
|
Allergic Reaction |
Rare but may require prompt medical attention |
Safety first: Severe, persistent, or worsening symptoms should not be self-managed; seek appropriate medical advice.
5 THINGS TO CHECK BEFORE USING PEGARK SUS
01. Follow Professional Advice
Use PEGARK SUS according to the recommended indication and dosing instructions.
02. Consider Your Hydration
Follow healthcare-professional advice regarding appropriate fluid intake.
03. Mention Relevant Medical Conditions
Inform your healthcare professional about significant gastrointestinal, kidney, or electrolyte-related conditions.
04. Avoid Unsupervised Prolonged Use
Do not continue laxative therapy beyond the recommended duration without professional guidance.
05. Recognize Warning Symptoms
Severe abdominal pain, persistent vomiting, significant diarrhoea, dehydration, or allergic symptoms warrant medical attention.
Remember: The safest approach is simpler: right indication, right dose, right duration.
PEGARK SUS + Monark Biocare: A New Pharma Growth Opportunity
PEGARK SUS can complement a gastrointestinal-focused pharmaceutical portfolio with its Polyethylene Glycol + electrolyte oral solution formulation and convenient 200 ml presentation.
Monark Biocare offers pharma business opportunities including PCD Pharma Franchise, Third Party Manufacturing, Ethical Promotion, Contract Manufacturing, Private Label Manufacturing, Institutional Supply, and Pan-India Distribution Support.
Whether you are expanding an existing range or developing a new gastrointestinal portfolio, Monark Biocare can support your pharmaceutical business journey with suitable product and partnership opportunities.
DISCLAIMER
This content is provided for general educational and product-information purposes only. PEGARK SUS should be used according to qualified healthcare-professional advice and approved product information. It is not a substitute for professional diagnosis or treatment.
5 QUICK ANSWERS
1️⃣ What is PEGARK SUS?
PEGARK SUS is a Polyethylene Glycol-based oral solution containing Sodium Chloride, Sodium Hydrogen Carbonate, and Potassium Chloride.
2️⃣ What is the main ingredient in PEGARK SUS?
The key ingredient is Polyethylene Glycol 13.125 gm, combined with three electrolytes.
3️⃣ How does Polyethylene Glycol work?
Polyethylene Glycol works through osmotic action, helping retain water in the intestinal tract and increase stool water content.
4️⃣ What are the common side effects?
Possible effects include bloating, gas, abdominal discomfort, nausea, and loose stools or diarrhoea.
5️⃣ How should PEGARK SUS be dosed?
The appropriate dosage depends on the patient, condition, and intended use. Follow the prescribed or approved dosing instructions rather than selecting a dose independently.
